Q4 2016
Released Mar 20, 2017, after the close
10-K filed Mar 20, 2017, 79 days after period end · 0001493152-17-002633
Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$746.00K$746.00K derived+45.4% vs Q4 2015+57.1% vs Q3 2016
Net Income-$655.00K-$655.00K derivedN/M vs Q4 2015N/M vs Q3 2016
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$386,000+52.0%
Operating Incomederived-$609,000N/M
Operating Cash Flowderived-$528,000N/M
Free Cash Flowderived-$528,000—
Margins · derived
Gross margin51.7%+2.2 pt vs Q4 2015
Operating margin-81.6%+100.4 pt vs Q4 2015
Net margin-87.8%+94.5 pt vs Q4 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $746.00K | $513.00K | $343.00K | $226.00K |
| Net Income | -$655.00K | -$935.00K | -$1.24M | $3.50M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR